The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DexCom receives a BUY rating due to strong growth, expanding margins, and the launch of Stelo, the first OTC CGM for non-insulin users. DXCM raised its 2025 outlook, targeting $4.6B+ in revenue, 62% ...

Medical device maker DexCom (NASDAQ: DXCM) has been trading in a fairly tight range recently, holding gains from the company’s third-quarter report in late October. The stock is up 16.33% in the past ...

The new offering from Dexcom and Welldoc will combine the former's wearable G6 sensor with the latter's digital app for personalized diabetes coaching. (Dexcom) () Coming off what it’s described as ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

Plenty of businesses, such as PepsiCo Inc. (NYSE: PEP) and Walmart Inc. (NYSE: WMT), have been under the microscope on fears of potential earnings decreases due to growing use of products like Novo ...

DexCom, Inc. DXCM has been struggling lately, but the selling pressure may be coming to an end soon. That is because DXCM recently saw a Hammer Chart Pattern which can signal that the stock is nearing ...